Analysis and Perspectives

Apr 24, 2023

Bronchiectasis is a chronic respiratory condition where the bronchial tubes in the lungs become damaged, inflamed, and widened, leading to a buildup of mucus that makes breathing difficult. The condition can develop for various reasons, including infections, genetic disorders, autoimmune conditions, and other facto...

Apr 21, 2023

To address challenges, pharma giants GSK & Pfizer are bringing first vaccine for respiratory syncytial virus treatment to adult population.

Apr 19, 2023

The Body Contouring Devices market is evolving at an immense pace due to the ongoing trends and developments in the domain. Companies are developing new products

Apr 14, 2023

Vertex & CRISPR Therapeutics become first companies to submit marketing application for CRISPR gene-editing therapy exa-cel for SCD & TDT.

Apr 14, 2023

DelveInsight has analyzed some of the key abstracts and top data readouts from the American Association for Cancer Research (AACR) 2023. Several pharma and biotech companies

Apr 12, 2023

Polymerase Chain Reaction Market is evolving at an immense pace. Several companies are working in the domain. Major trends and developments

Apr 07, 2023

The pipeline is very robust as over 75 leading companies are developing novel therapies for plaque psoriasis treatment.

Apr 05, 2023

The Drug Delivery Devices Market is evolving at an immense pace owing to ongoing developments in the domain. Several major companies are developing new devices

Apr 03, 2023

DAYBUE (trofinetide) by Acadia Pharmaceuticals & Neuren Pharmaceuticals became the first & only FDA-approved drug for Rett syndrome treatment.

Mar 31, 2023

Cell therapies open doors for advanced peripheral artery disease treatment and are discussed comprehensively as novel regenerative medicine.